Literature DB >> 204660

Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen.

D Baron, J L Strominger.   

Abstract

The Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA) was purified 85-fold from a nuclear pellet derived from an EBV-transformed B lyphoblastoid cell line by a five-step procedure consisting of preparation of extract, heating at 80 degrees C in phosphate buffer, ammonium sulfate precipitation, preparative ultracentrifugation, and affinity chromatography on double-stranded DNA-cellulose. The purified complement fixing antigen specifically blocked the anticomplement immunofluorescence assay for EBNA. Several properties indicate a close association of EBNA with chromatin, viz. 1) precipitation of antigenic activity by phosphate buffer and subsequent thermal fractionation; 2) partial sensitivity of antigenic activity to DNase (but not to RNase) and restoration of activity by addition of calf thymus DNA; and 3) specific binding of EBNA to double-stranded DNA-cellulose. Other properties of EBNA, including its unusual heat stability, are described.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines.

Authors:  J Luka; T Lindahl; G Klein
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

2.  Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit.

Authors:  J Luka; H Jörnvall; G Klein
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

3.  Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen.

Authors:  T C Spelsberg; T B Sculley; G M Pikler; J A Gilbert; G R Pearson
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

4.  Cloning and mapping of BamHi endonuclease fragments of DNA from the transforming B95-8 strain of Epstein-Barr virus.

Authors:  J Skare; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

5.  Epstein-barr Virus (EBV) intracellular antigens: factors affecting the patterns of immunofluorescence.

Authors:  A M Favart; M E Lamy; G Burtonboy
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

6.  Antibodies to EB virus- and cytomegalovirus-induced antigens in early rheumatoid disease.

Authors:  D Male; A Young; C Pilkington; S Sutherland; I M Roitt
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

7.  Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.

Authors:  E A Grogan; W P Summers; S Dowling; D Shedd; L Gradoville; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

Review 8.  Epstein-Barr virus (EBV), lymphocytes and transformation.

Authors:  J Zeuthen
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

9.  Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.

Authors:  D K Fischer; M F Robert; D Shedd; W P Summers; J E Robinson; J Wolak; J E Stefano; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA.

Authors:  W P Summers; E A Grogan; D Shedd; M Robert; C R Liu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.